Article
Rapid detection of hepatitis C virus using recombinase polymerase amplification
25 Oct 2022
Abstract excerpt
Over 71 million people are infected with hepatitis C virus (HCV) worldwide, and approximately 400,000 global deaths result from complications of untreated chronic HCV. Pan-genomic direct-acting antivirals (DAAs) have recently become widely available and feature high cure rates in less than 12 weeks of treatment. The rollout of DAAs is reliant on diagnostic tests for HCV RNA to identify eligible patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
